To be or not to be (inflamed) – is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?

2005 ◽  
Vol 26 (10) ◽  
pp. 517-525 ◽  
Author(s):  
Bianca Marchetti ◽  
Maria P. Abbracchio
Keyword(s):  
Drug Therapy ◽  
Neurodegenerative Disorders ◽  
Inflammatory Drug ◽  
Anti Inflammatory

Potential complications of nonsteroidal anti-inflammatory drug therapy

1989 ◽  
Vol 79 (12) ◽  
pp. 605-614
Author(s):  
GD Corrigan ◽  
L Pantig-Felix ◽  
IO Kanat
Keyword(s):  
Health Care ◽  
Patient Satisfaction ◽  
Drug Therapy ◽  
Side Effects ◽  
Mechanism Of Action ◽  
Drug Class ◽  
Inflammatory Drug ◽  
The Us ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Since indomethacin was first marketed, some 40 years ago, the class of nonsteroidal anti-inflammatory drugs has grown larger than any other drug class in history. At present, there are at least 25 such drugs being used in the US and abroad, both clinically and in research. Despite their widespread use, their implications to health care are just beginning to be understood. The authors review updated theories on the mechanism of action, side effects, and drug interactions of nonsteroidal anti-inflammatory drug therapy. Proposed guidelines for monitoring their use are given. A more thorough understanding of the risks-to-benefits ratio is provided in an effort to achieve maximum patient satisfaction and safety.

Sign in / Sign up

Export Citation Format

Share Document